カテゴリ： Allied Market Research, 世界, 医療/バイオ

先進臨床判断支援プラットフォームのグローバル市場（2021～2031）：治療、診断

■ 英語タイトル：Advanced Clinical Decision Support Platforms Market By Type (Therapeutic, Diagnostic), By Model (Knowledge based, Non Knowledge based), By Setting (Hospitals, Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA077）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA077
■ 発行日：2023年2月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：241
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥535,500見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥859,500見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,440,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[先進臨床判断支援プラットフォームのグローバル市場（2021～2031）：治療、診断]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社発行の最新調査レポートでは、世界の先進臨床判断支援プラットフォーム市場規模が2022年から2031年にかけて年平均9.0％成長し、2021年の496.4 millionドルから2031年には1,175.0 million ドルに達すると予測しています。当レポートは、先進臨床判断支援プラットフォームの世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別（治療、診断）分析、モデル別（知識ベース、非知識ベース）分析、施設別（病院、外来診療所）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東/アフリカ）分析、企業状況など、多面的な分析結果をまとめたものです。なお、企業情報として、Oracle Corporation、Wolters Kluwer、Meditech、IBM Watson Health、Veradigm Inc.、Epic Systems Corporation、NextGen Healthcare Inc.、Zynx health、Siemens Healthineers、Relx Groupなどが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の先進臨床判断支援プラットフォーム市場規模：種類別
　 - 治療支援プラットフォームの市場規模
　 - 診断支援プラットフォームの市場規模
・世界の先進臨床判断支援プラットフォーム市場規模：モデル別
　 - 臨床知識ベースの市場規模
　 - 臨床非知識ベースの市場規模
・世界の先進臨床判断支援プラットフォーム市場規模：施設別
　 - 病院における市場規模
　 - 外来診療所における市場規模
・世界の先進臨床判断支援プラットフォーム市場規模：地域別
　 - 北米の先進臨床判断支援プラットフォーム市場規模
　 - ヨーロッパの先進臨床判断支援プラットフォーム市場規模
　 - アジア太平洋の先進臨床判断支援プラットフォーム市場規模
　 - 中南米・中東/アフリカの先進臨床判断支援プラットフォーム市場規模
・企業状況
・企業情報

The Advanced Clinical Decision Support Platforms Market valued for $496.4 million in 2021 and is estimated to reach $1,175.0 million by 2031, exhibiting a CAGR of 9.0% from 2022 to 2031. 
Advanced clinical decision support platforms or computerized clinical decision support systems (CDSS) represent a paradigm shift in healthcare sector. CDSS are used to augment clinicians in their complex decision-making processes. It is a type of system that offers health information technology to doctors, staff, patients, and other individuals with knowledge and person-specific information that are intelligently filtered or provided at the right moment to enhance health and health care. Clinical decision support systems are core component of electronic health records. These tools can alert the physician about potential errors, remind them to provide preventive care, help them to make diagnosis, and assist with treatment.
The growth of advanced clinical decision support platforms market is driven by technological advancement in the development of different clinical decision support systems and increase in number of various strategies adopted such as product launch and product approval by the key market players. In addition, rise in government initiatives for promoting digital healthcare boosts the market growth. Governments across the world are increasingly taking steps to promote digital health and the use of advanced clinical decision support systems. Thus, this factor is attributed to drive the demand for advanced clinical decision support systems and fuel the growth of market.
Moreover, there is rise in the prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, which drives the demand for advanced clinical decision support systems, as these systems help healthcare professionals to provide better care for such conditions. Clinical decision support systems (CDSSs) can help clinicians to assess cardiovascular disease (CVD) risk & manage CVD risk factors by providing tailored assessments and treatment recommendations based on individual patient data. As Cardiovascular disease is the term for all types of diseases that affect the heart or blood vessels, including coronary heart disease, which can cause heart attacks, stroke, congenital heart defects, therefore, clinical decision support system can also be useful in treatment of coronary heart disease.
Thus, rise in prevalence of coronary heart disease fosters the demand for advanced clinical decision support system by physicians and fuels the growth of market. For instance, according to report shared by Center for Disease Control and Prevention (CDC), it was reported that, coronary heart disease is the most common type of heart disease, killing 382,820 people in the U.S. in 2020. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) were in adults less than 65 years old.
Clinical decision support systems are often integrated into telemedicine clinical practice. Thus, rise in usage of telemedicine platform by physician contributes to the growth of market. For instance, according to Centers for Disease Control and Prevention (CDC) in December 2022, it was reported that, from 2019 to 2021, the use of telemedicine technology increased for office-based physicians from 15.4% to 85.9%. In both 2019 and 2021, the use of telemedicine technology was higher among primary care physicians and medical specialty physicians On the other hand, high cost of electronic health record systems and cyber security issues associated with advanced clinical decision support platforms are some factors that are anticipated to restrain the growth of the advanced clinical decision support platforms market.

The advanced clinical decision support platforms market is segmented into type, model, setting, and region. By type, the market is bifurcated into therapeutic and diagnostic. The diagnostic segment is further bifurcated into hospitals and ambulatory care. Therapeutic segment is further subdivided into hospitals and ambulatory care. By model, the market is divided into knowledge based and non-knowledge based. By setting, the market is classified into hospital and ambulatory care.

Region-wise; the market is analyzed across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).  Some of the major companies that operate in the global advanced clinical decision support platforms market include Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced clinical decision support platforms market analysis from 2021 to 2031 to identify the prevailing advanced clinical decision support platforms market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the advanced clinical decision support platforms market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global advanced clinical decision support platforms market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Model
● Knowledge based
● Non Knowledge based

By Setting
● Ambulatory care
● Hospitals

By Type
● Therapeutic
○ Setting
○ Hospitals
○ Ambulatory care
● Diagnostic
○ Setting
○ Hospitals
○ Ambulatory care

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Oracle Corporation
○ Wolters Kluwer
○ Meditech
○ IBM Watson Health
○ Veradigm Inc.
○ Epic Systems Corporation
○ NextGen Healthcare Inc.
○ Zynx health
○ Siemens Healthineers
○ Relx Group

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in incidence of medication error
3.4.1.2. Increase in application of electronic health record system
3.4.1.3. Rise in geriatric population and increase in prevalence of chronic diseases

3.4.2. Restraints
3.4.2.1. Data security concerns related to cloud based CDSS
3.4.2.2. Increase in the incidence of data breach

3.4.3. Opportunities
3.4.3.1. Increase in number of adoptions of key strategies for development of market

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Therapeutic
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
4.2.4.1. Hospitals Market size and forecast, by region
4.2.4.2. Ambulatory care Market size and forecast, by region
4.3. Diagnostic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
4.3.4.1. Hospitals Market size and forecast, by region
4.3.4.2. Ambulatory care Market size and forecast, by region
CHAPTER 5: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Knowledge based
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Non Knowledge based
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory care
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.2.1. North America Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
7.2.2.2. North America Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
7.2.3. Market size and forecast, by Model
7.2.4. Market size and forecast, by Setting
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Model
7.2.5.1.4. Market size and forecast, by Setting
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Model
7.2.5.2.4. Market size and forecast, by Setting
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Model
7.2.5.3.4. Market size and forecast, by Setting
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.2.1. Europe Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
7.3.2.2. Europe Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
7.3.3. Market size and forecast, by Model
7.3.4. Market size and forecast, by Setting
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Model
7.3.5.1.4. Market size and forecast, by Setting
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Model
7.3.5.2.4. Market size and forecast, by Setting
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Model
7.3.5.3.4. Market size and forecast, by Setting
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Model
7.3.5.4.4. Market size and forecast, by Setting
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Model
7.3.5.5.4. Market size and forecast, by Setting
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Model
7.3.5.6.4. Market size and forecast, by Setting
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.2.1. Asia-Pacific Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
7.4.2.2. Asia-Pacific Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
7.4.3. Market size and forecast, by Model
7.4.4. Market size and forecast, by Setting
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Model
7.4.5.1.4. Market size and forecast, by Setting
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Model
7.4.5.2.4. Market size and forecast, by Setting
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Model
7.4.5.3.4. Market size and forecast, by Setting
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Model
7.4.5.4.4. Market size and forecast, by Setting
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Model
7.4.5.5.4. Market size and forecast, by Setting
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Model
7.4.5.6.4. Market size and forecast, by Setting
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.2.1. LAMEA Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
7.5.2.2. LAMEA Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
7.5.3. Market size and forecast, by Model
7.5.4. Market size and forecast, by Setting
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Model
7.5.5.1.4. Market size and forecast, by Setting
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Model
7.5.5.2.4. Market size and forecast, by Setting
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Model
7.5.5.3.4. Market size and forecast, by Setting
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Model
7.5.5.4.4. Market size and forecast, by Setting
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. IBM Watson Health
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Meditech
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. NextGen Healthcare Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Siemens Healthineers
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Veradigm Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Wolters Kluwer
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Zynx health
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Oracle Corporation
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Epic Systems Corporation
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. Relx Group
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 02. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 04. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
TABLE 06. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GLOBAL DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 08. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 11. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 12. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 14. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 22. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 24. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 25. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 26. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 27. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 28. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 29. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 30. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 31. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 32. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 33. EUROPE THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 34. EUROPE DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 35. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 36. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 37. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 40. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 41. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 43. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 44. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 46. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 47. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 49. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 50. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 52. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 53. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 55. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 56. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 57. ASIA-PACIFIC THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 58. ASIA-PACIFIC DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 59. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 60. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 61. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 62. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 63. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 64. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 65. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 66. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 67. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 68. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 70. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 71. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 73. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 74. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 76. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 80. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 81. LAMEA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 82. LAMEA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 83. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 84. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 85. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 86. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 87. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 88. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 89. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 92. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 95. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 96. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
TABLE 97. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
TABLE 98. IBM WATSON HEALTH: KEY EXECUTIVES
TABLE 99. IBM WATSON HEALTH: COMPANY SNAPSHOT
TABLE 100. IBM WATSON HEALTH: PRODUCT SEGMENTS
TABLE 101. IBM WATSON HEALTH: PRODUCT PORTFOLIO
TABLE 102. IBM WATSON HEALTH: KEY STRATERGIES
TABLE 103. MEDITECH: KEY EXECUTIVES
TABLE 104. MEDITECH: COMPANY SNAPSHOT
TABLE 105. MEDITECH: SERVICE SEGMENTS
TABLE 106. MEDITECH: PRODUCT PORTFOLIO
TABLE 107. NEXTGEN HEALTHCARE INC.: KEY EXECUTIVES
TABLE 108. NEXTGEN HEALTHCARE INC.: COMPANY SNAPSHOT
TABLE 109. NEXTGEN HEALTHCARE INC.: PRODUCT SEGMENTS
TABLE 110. NEXTGEN HEALTHCARE INC.: PRODUCT PORTFOLIO
TABLE 111. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 112. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 113. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
TABLE 114. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 115. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 116. VERADIGM INC.: KEY EXECUTIVES
TABLE 117. VERADIGM INC.: COMPANY SNAPSHOT
TABLE 118. VERADIGM INC.: PRODUCT SEGMENTS
TABLE 119. VERADIGM INC.: PRODUCT PORTFOLIO
TABLE 120. VERADIGM INC.: KEY STRATERGIES
TABLE 121. WOLTERS KLUWER: KEY EXECUTIVES
TABLE 122. WOLTERS KLUWER: COMPANY SNAPSHOT
TABLE 123. WOLTERS KLUWER: SERVICE SEGMENTS
TABLE 124. WOLTERS KLUWER: PRODUCT PORTFOLIO
TABLE 125. WOLTERS KLUWER: KEY STRATERGIES
TABLE 126. ZYNX HEALTH: KEY EXECUTIVES
TABLE 127. ZYNX HEALTH: COMPANY SNAPSHOT
TABLE 128. ZYNX HEALTH: PRODUCT SEGMENTS
TABLE 129. ZYNX HEALTH: PRODUCT PORTFOLIO
TABLE 130. ORACLE CORPORATION: KEY EXECUTIVES
TABLE 131. ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 132. ORACLE CORPORATION: PRODUCT SEGMENTS
TABLE 133. ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 134. ORACLE CORPORATION: KEY STRATERGIES
TABLE 135. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 136. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 137. EPIC SYSTEMS CORPORATION: SERVICE SEGMENTS
TABLE 138. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 139. EPIC SYSTEMS CORPORATION: KEY STRATERGIES
TABLE 140. RELX GROUP: KEY EXECUTIVES
TABLE 141. RELX GROUP: COMPANY SNAPSHOT
TABLE 142. RELX GROUP: SERVICE SEGMENTS
TABLE 143. RELX GROUP: PRODUCT PORTFOLIO
TABLE 144. RELX GROUP: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ビチューメン乳化剤のグローバル市場（2021～2031）：アニオン性、カチオン性、非イオン性
  • ビチューメン乳化剤のグローバル市場（2021～2031）：アニオン性、カチオン性、非イオン性
  • 研究所装置＆消耗品のグローバル市場（2021-2031）：装置、消耗品
  • ブラストミセス症のグローバル市場（2021〜2031）：錠剤、軟膏、粉末、液体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA077 )"先進臨床判断支援プラットフォームのグローバル市場（2021～2031）：治療、診断" (英文：Advanced Clinical Decision Support Platforms Market By Type (Therapeutic, Diagnostic), By Model (Knowledge based, Non Knowledge based), By Setting (Hospitals, Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。